Nuclear Regulatory Commission March 29, 2011 – Federal Register Recent Federal Regulation Documents

SUNSHINE FEDERAL REGISTER NOTICE
Document Number: 2011-7456
Type: Notice
Date: 2011-03-29
Agency: Nuclear Regulatory Commission, Agencies and Commissions
Advisory Committee on the Medical Uses of Isotopes: Meeting
Document Number: 2011-7322
Type: Proposed Rule
Date: 2011-03-29
Agency: Nuclear Regulatory Commission, Agencies and Commissions
NRC will convene a meeting of the Advisory Committee on the Medical Uses of Isotopes (ACMUI) on April 11-12, 2011. This will be a public meeting, and the final agenda is under development. A sample of agenda items to be discussed during this session includes: (1) Written directives and medical event reporting for permanent implant brachytherapy; (2) amending preceptor attestation requirements, (3) extending grandfathering to certain certified individuals regarding training and experience requirements (Petition for Rulemaking (PRM 35- 20, Ritenour Petition); (4) dose limits to members of the public (per year versus per treatment) from patients who have been administered radioiodine; (5) a subcommittee report on medical-related events; and (6) a variety of other topics related to 10 Code of Federal Regulations (CFR) Part 35 rulemaking. Once finalized, a copy of the agenda will be available at https://www.nrc.gov/reading-rm/doc-collections/acmui/agenda or by e-mailing Ms. Sophie Holiday at the contact information below. The primary purpose of the meeting is for the NRC to seek comments and insights from the members of the ACMUI. However, NRC will also welcome public participation and comments on the rulemaking topics listed above. The meeting's purpose is to discuss current rulemaking activities related to 10 CFR Part 35, Medical Use of Byproduct Material.
South Texas Project Nuclear Operating Company; Establishment of Atomic Safety and Licensing Board
Document Number: 2011-7320
Type: Notice
Date: 2011-03-29
Agency: Nuclear Regulatory Commission, Agencies and Commissions
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.